Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Joel W Hughes , Andrea Bon-Wilson , Kent Eichenauer , et al Added: 3 years ago
In a recent meeting with department heads from psychiatry and cardiology, the possibility of hiring a behavioral medicine specialist (e.g. a psychologist) to work exclusively with cardiac and pulmonary patients was discussed. One cardiologist said, “I could probably refer you seven patients every Tuesday.” Whatever clinic he was referring to, it was clear to all in attendance that patients with… View more
Research Area(s) / Expertise:

Imaging

Cardio-oncology

Congenital Heart Disease

Job title: Director
A cardiologist with board certification, Dr. Wu. is the Simon H. Stertzer, MD, Professor of Medicine and Radiology at Stanford University School of Medicine and the director of the Stanford Cardiovascular Institute. Dr. Wu was also chosen by the American Heart Association to serve as its president-elect for the 2022–2023 fiscal year. He conducts extensive research focussing on clinical… View more
Author(s): Digisonics Inc Added: 3 years ago
For the second consecutive year, Digisonics achieved Best in KLAS for Cardiology in 2009, validating its status as the top-rated cardiovascular software solution in the world. According to the 2009 Best in KLAS Awards: Software & Professional Services report (www.KLASresearch.com), Digisonics received an overall score approximately five points higher than its nearest competitors. In addition,… View more
Research Area(s) / Expertise:

Heart Failure

Job title: Professor of Nursing
ProfDavid Thompson is Professor of Nursing, Queen’s University, Belfast, Northern Ireland.He is a Visiting Professor at University College Dublin and La Trobe University, Melbourne, Professorial Fellow at the University of Melbourne, Adjunct Professor at Monash University, Honorary Professor at the University of Queensland, and Distinguished Professor at Anhui Medical University. He has served… View more
Author(s): Alexander Fanaroff Added: 4 weeks ago
CRT 24 - Dr Alexander Fanaroff (Penn Medicine, US) joins us in this short interview to discuss the findings of a national cohort of patients with chronic limb-threatening ischemia, CLIPPER.The CLIPPER cohort includes the baseline data and outcomes of 1.13 million patients with chronic limb-threatening ischemia.Findings from the study showed that for individuals with a diagnosis to limb… View more
Author(s): Erik B Friedrich , Michael Böhm Added: 3 years ago
Chronic heart failure (CHF) is a major public health problem in industrialized societies with an incidence approaching 10 per 1,000 population after age 65 and an age-dependent prevalence of less than 1% between ages 45-55, 2-5% between ages 65-75, and approximately 10% for patients aged 80 years or more.Thus, HF is primarily a condition of the elderly and approximately 80% of patients… View more
Job title: Lead Nurse and Director of Clinical Services
At UK Vein Clinic, Vanessa supports patients during their procedures and also leads the clinical pathway and aftercare team.Vanessa was born and raised in California, where she initially attended UC Berkeley for a BA in History, before she went on to complete a Bachelor of Nursing degree at the University of Glasgow. With a background in cardiovascular theatre nursing, Vanessa worked at St Thomas… View more
Author(s): Srinivas Murali Added: 3 years ago
Pulmonary arterial hypertension (PAH) is a disease affecting the pulmonary vascular endothelium of the small pulmonary vessels that causes progressive elevations in pulmonary vascular resistance, leading to right ventricular failure and death. PAH can result from a number of causes or associated risk factors. A clinical classification (Evian classification) was developed in 1993 and subsequently… View more
Author(s): Nicolas M Van Mieghem Added: 5 years ago
An analysis of the late-breaking trials from ACC 2019 presented by Dr Nicolas van Mieghem (Erasmus MC, Rotterdam, NL). Filmed on site at ACC 2019 by Radcliffe Cardiology Topics: 00:19 - Apple Heart Study 01:50 - PARTNER 3 Trial 03:44 - CoreValve Low Risk Study 06:26 - STS/TVT Registry Sub-Analysis 07:32 - COAPT Quality of Life Analysis 07:43 - COAPT Echo Sub-Analysis 08:14 - AUGUSTUS… View more
Author(s): Peter H Brubaker Added: 3 years ago
Heart failure (HF), most simply defined as the inability of the heart to meet the demands of the tissue, results in symptoms of fatigue or dyspnea on exertion (progressing to dyspnea at rest), and is a costly and deadly disorder.1 HF is the only cardiovascular disease entity where the incidence is currently increasing. In 1991 there were ‘just’ 3.5 million reported cases of HF in the US; however,… View more